Utility of 18F-FDG PET/CT in the Surveillance of Patients With Neurofibromatosis Type 1.

Tanase MG, Djilani L, Lamontagne R, Derbel R, Baril M, Roy V, Blais M, Buteau FA, Khuong HT, Gros-Louis F, Leclerc M, Dupre N.